Peripheral blood inflammatory markers in depression: Response to electroconvulsive therapy and relationship with cognitive performance

• Published in: Psychiatry research Vol. 315; p. 114725
• Main Authors: Ryan, Karen M., McLoughlin, Declan M.
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01-09-2022
• Subjects: Cognition; ECT; Immune response; Inflammation; Inflammation; Cognition; Immune response; ECT
• ISSN: 0165-1781; 1872-7123
• DOI: 10.1016/j.psychres.2022.114725

•CRP, IL-6, IL-10, and TNF-α were higher in depressed patients than in controls.•ECT did not alter inflammatory mediator concentrations.•We found no relationship between inflammatory mediators and mood or cognition.
The inflammatory response may play a role in depression and the response to antidepressants. Electroconvulsive therapy (ECT), the most acutely powerful antidepressant treatment, can also affect the innate immune system. Here, we determined circulating blood concentrations of the inflammatory mediators C-reactive protein (CRP), IL-1β, IL-6, IL-10, and TNF-α in depressed patients compared to healthy controls and assessed the effect of ECT on their concentrations. Relationships between inflammatory mediator concentrations and mood/cognition scores were also explored. Plasma CRP, IL-1β, IL-6, IL-10, and TNF-α concentrations were examined in 86 depressed patients and 57 controls. Relationships between inflammatory mediators and clinical or cognitive outcomes following ECT were assessed using correlation and linear regression analyzes, respectively. CRP, IL-6, IL-10, and TNF-α were elevated in patients at baseline/pre-ECT compared to controls. However, only IL-6 and TNF-α survived adjustment for potential confounders. IL-1β was undetectable in most samples. ECT did not significantly alter plasma concentrations of any of the inflammatory mediators. No relationship was identified between CRP, IL-6, IL-10, and TNF-α and mood or neurocognitive scores. Overall, our data do not support a major role for these four inflammatory markers in clinical outcomes following ECT or in cognition.